Magnetic iron oxide nanoparticles for Tumor-Targeted Therapy

Current Cancer Drug Targets

Volumn 11, Issue 2, 2011, Pages 184-189

  Chen, B ^a,b   Wu, W ^a,b   Wang, X ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Drug delivery; Hyperthermia; Iron oxide; Magnetic nanoparticle; Surface modification; Targeted therapy

Indexed keywords

CARBOHYDRATE DERIVATIVE; CHITOSAN; IRON OXIDE; MACROGOL; MAGNETIC NANOPARTICLE;

ARTICLE; CANCER THERAPY; CONTRAST ENHANCEMENT; DRUG DELIVERY SYSTEM; HUMAN; HYPERTHERMIC THERAPY; MAGNETISM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; FERRIC COMPOUNDS; HUMANS; HYPERTHERMIA, INDUCED; MAGNETIC FIELD THERAPY; METAL NANOPARTICLES; NANOMEDICINE; NEOPLASMS; SURFACE PROPERTIES;

EID: 79551629919     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800911794328475     Document Type: Article

References (85)

1. Alexiou, C.; Arnold, W.; Klein, R. J.; Parak, F. G.; Hulin, P.; Bergemann, C.; Erhardt, W.; Wagenpfeil, S.; Lubbe, A. S. Locoregional cancer treatment with magnetic drug targeting. Cancer Res.2006, 60, 6641-6648.
2. Alexiou, C.; Jurgons, R.; Schmid, R. J.; Bergemann, C.; Henke, J.; Erhardt, W.; Huenges, E.; Parak, F. Magnetic drug targetingbiodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. J. Drug Target 2003, 11, 139-149.
3. Ito, A.; Tanaka, K.; Kondo, K.; Shinkai, M.; Honda, H.; Matsumoto, K.; Saita T.; Kobayashi, T. Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Sci. 2003, 94, 308-313.
4. Artemov D. Molecular magnetic resonance imaging with targeted contrast agents. J. Cell Biochem. 2003, 90, 518-524.
5. Weizmann, Y.; Patolsky, F.; Katz, E.; Willner, I. Amplified DNA sensing and immunosensing by the rotation of functional magnetic particles. J. Am. Chem. Soc. 2003, 125, 3452-3454.
6. Song, H. T.; Choi, J. S.; Huh, Y. M.; Kim, S. J.; Jun, Y. W.; Suh, J. S.; Cheon, J. W. Surface modulation of magnetic nanocrystals in the development of highly efficient magnetic resonance probes for intracellular labeling. J. Am. Chem. Soc. 2005, 127, 9992-9993.
7. Gao, X.; Cui, Y.; Levenson, R. M.; Chung, L. W.; Nie, S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 2004, 22, 969-976.
8. Long, Z.; Xie, M. Q.; Zhang, T.; Shen, H.; Xu, X. Q.; Guo, L. Effect of targeted therapy with cisplatin-loaded magnetic nanoparticles combined with radiotherapy for nasopharyngeal carcinoma in nude mice. Nan Fang Yi Ke Da Xue Xue Bao. 2009, 29, 1827-1830.
9. 4 nanoparticles and their applications in cell labeling and in vivo imaging. J. Nanobiotechnol. 2010, 8, 25.
10. 4 in anticancer drug carriers with target-orientation and sustainedrelease properties. Biomed. Mater. 2007, 2, 132-134.
11. Xie, H. Y.; Zuo, C.; Liu, Y.; Zhang, Z. L.; Pang, D. W.; Li, X. L.; Gong, J. P.; Dickinson, C.; Zhou, W. Cell-targeting multifunctional nanospheres with both fluorescence and magnetism. Small. 2005, 1, 506-509.
12. Gupta, A. K.; Gupta, M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26, 3995-4021.
13. Gupta, A. K.; Naregalkar, R. R.; Vaidya, V. D.; Gupta, M. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine 2007, 2, 23-39.
14. McCarthy, J. R.; Kelly, K. A.; Sun, E. Y.; Weissleder, R. Targeted delivery of multifunctional magnetic nanoparticles. Nanomedicine 2007, 2, 153-167.
15. Duguet, E.; Vasseur, S.; Mornet, S.; Devoisselle, J. M. Magnetic nanoparticles and their applications in medicine. Nanomedicine 2006, 1, 157-168.
16. Ito, A.; Tanaka, K.; Kondo, K.; Shinkai, M.; Honda, H.; Matsumoto, K.; Saida, T.; Kobayashi, T. Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Sci. 2003, 94, 308-313.
17. Ito, A.; Matsuoka, F.; Honda, H.; Kobayashi, T. Heat shock protein 70 gene therapy combined with hyperthermia using magnetic nanoparticles. Cancer Gene Ther. 2003, 10, 918-925.
18. Tartaj, P.; Morales, M. P.; Veintemillas-Verdaguer, S.; Gonzalez- Carreno, T.; Serna, C. J. The preparation of magnetic nanoparticles for applications in biomedicine. J. Phys. D: Appl. Phys. 2003, 36, R182-R197.
19. Ito, A.; Shinkai, M.; Honda, H.; Kobayashi, T. Medical application of functionalized magnetic nanoparticles, J. Biosci. Bioeng. 2005, 100, 1-11.
20. 4 magnetic nanoparticles. Biochem. Eng. J. 2008, 42, 290-300.
21. Lu, A. H.; Salabas, E. L.; Schuth, F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew. Chem. Int. Ed. Engl. 2007, 46, 1222-1244.
22. Dobrovolskaia, M. A.; McNeil, S. E. Immunological properties of engineered nanomaterials. Nat. Nanotechnol. 2007, 2, 469-478.
23. Kim, S.; Kim, J. H.; Jeon, O.; Kwon, I. C.; Park, K. Engineered polymers for advanced drug delivery. Eur. J. Pharm. Biopharm. 2009, 71, 420-430.
24. Alexioua, C.; Jurgons, R.; Schmid, R.; Hilpert, A.; Bergemann, C.; Parak, F.; Iro, H. In vitro and in vivo investigations of targeted chemotherapy with magnetic nanoparticles. J. Magn. Magn. Mater. 2005, 293, 389-393.
25. 1 Synthesis of organosoluble, palladium adsorbable, and biodegradable chitosan derivatives toward the chemical plating on plastics. Biomacromolecules 2002, 3, 1120-1125.
26. Zhu, A.; Yuan, L.; Dai, S. Preparation of well-disperse superparamagnetic iron oxide nanoparticles in an aqueous solution with biocompatible N-succinyl-O-carboxymethylchitosan. J. Phys. Chem. C 2008, 112, 5432-5438.
27. 4 nanoparticles stabilized by chitosan and O-carboxymethylchitosan. Int. J. Pharm. 2008, 350, 361-368.
28. Zhao, A.; Yao, P.; Kang, C.; Yuan, X.; Chang, J.; Pu, P. Synthesis and characterization of tat-mediated O-CMC magnetic nanoparticles having anticancer function. J. Magn. Magn. Mater. 2005, 295, 37-43.
29. Kim, J. H.; Kim, Y. S.; Kim, S.; Park, J. H.; Kim, K.; Choi, K.; Chung, H.; Jeong, S. Y.; Park, R. W.; Kim, I. S.; Kwon, I.C. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. J. Control Release 2006, 111, 228-234.
30. Hu, F. Q.; Ren, G. F.; Yuan, H.; Du, Y. Z.; Zeng, S. Shell crosslinked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel. Colloids Surf. B Biointerfaces 2006, 50, 97-103.
31. Reverchon, E.; Antonacci, A. Chitosan microparticles production by supercritical fluid processing. Ind. Eng. Chem. Res. 2006, 45, 5722-5728.
32. J. The effect of the physicochemical properties of a drug on its release from chitosonium malate matrix tablets. Int. J. Pharm. 1993, 100, 257-261.
33. 4 nanoparticles for camptothecin loading and release. Acta Biomater. 2009, 5, 1489-1498.
34. Zhu, L.; Ma, J.; Jia, N.; Zhao, Y.; Shen, H. Chitosan-coated magnetic nanoparticles as carriers of 5-Fluorouracil: Preparation, characterization and cytotoxicity studies. Colloids Surf. B Biointerfaces 2009, 68, 1-6.
35. Kamruzzaman Selim, M. K.; Ha, Y. S.; Kim, S. J.; Chang, Y.; Kim, T. J.; Ho Lee, G.; Kang, I. K. Surface modification of magnetite nanoparticles using lactobionic acid and their interaction with hepatocytes. Biomaterials 2007, 28, 710-716.
36. Kim, I. S.; Kim, S. H. Development of polymeric nanoparticulate drug delivery systems: evaluation of nanoparticles based on biotinylated poly(ethylene glycol) with sugar moiety. Int. J. Pharm. 2003, 257, 195-203.
37. Kekkonen, V.; Lafreniereet, N.; Ebara, M.; Saito, A.; Sawa, Y.; Narain, R. Synthesis and characterization of biocompatible magnetic glyconanoparticles. J. Magn. Magn. Mater. 2009, 321, 1393-1396.
38. Gupta, A. K.; Curtis, A. S. Surface modified superparamagnetic nanoparticles for drug delivery: interaction studies with human fibroblasts in culture. J. Mater. Sci, Mater. Med. 2004, 15, 493-496.
39. Harris, J. M.; Martin, N. E.; Modi, M. Pegylation: a novel process for modifying pharmacokinetics. Clin. Pharmcokinet. 2001, 40, 539-551.
40. Zhang, Y.; Kohler, N.; Zhang, M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 2002, 23, 1553-1561.
41. Yamazaki, M.; Ito, T. Deformation and instability of membrane structure of phospholipid vesicles caused by osmophobic association: mechanical stress model for the mechanism of poly(ethylene glycol)-induced membrane fusion. Biochemistry 1990, 29, 1309-1314.
42. Chen, J. Y.; Liao, Y. L.; Wand, T. H.; Lee, W. C. Transformation of Escherichia coli mediated by magnetic nanoparticles in pulsed magnetic field. Enzyme Microb. Technol. 2006, 39, 366-370.
43. Kichler, A.; Chillon, M.; Leborgne, C.; Danos, O.; Frisch, B. Intranasal gene delivery with a polyethylenimine-PEG conjugate. J. Control Release 2002, 81, 379-388.
44. 4 nano-magnetic fluid by co-precipitation method. Trans. Nonferrous Met. Soc. China 2008, 18, 393-398.
45. Chouly, C.; Pouliquen, D.; Lucet, I.; Jeune, J. J.; Jallet, P. Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. J. Microencapsul. 1996, 13, 245-255.
46. 4 nanoparticles for reduced non-specific uptake by macrophage cells. Adv. Mater. 2007, 19, 3163-3166.
47. 4 nanoparticles. J. Biomed. Mater. Res. A. 2007, 80, 333-341.
48. 4 magnetic composite latex particle that is synthesized by a novel method. Eur. Polym. J. 2008, 44, 2768-2776.
49. 4/amino-silane core-shell nanoparticles via layer-by-layer method. Appl. Surface Sci. 2009, 255, 7974-7980.
50. Mejías, R.; Costo, R.; Roca, A. G.; Arias, C. F.; Veintemillas- Verdaguer, S.; González-Carreño T.; del Puerto Morales, M.; Serna, C. J.; Mañes, S.; Barber, D.F. Cytokine adsorption/release on uniform magnetic nanoparticles for localized drug delivery. J. Control. Release 2008, 130, 168-174.
51. Ma, H. L.; Xu, Y. F.; Qi, X. R.; Maitani, Y.; Nagai, T. Superparamagnetic iron oxide nanoparticles stabilized by alginate: Pharmacokinetics, tissue distribution, and applications in detecting liver cancers. Int. J. Pharm. 2008, 354, 217-226.
52. Zhou, J.; Leuschner, C.; Kumar, C.; Hormes, J. F.; Soboyejo, W. O. Sub-cellular accumulation of magnetic nanoparticles in breast tumors and metastases. Biomaterials 2006, 27, 2001-2008.
53. E.; Cohen-Jonathana, S.; Linassier, C.; Douziech- Eyrolles, L.; Marchais, H.; Soucé M.; Hervé, K.; Dubois, P.; Chourpa, I. Novel method of doxorubicin-SPION reversible association for magnetic drug targeting. Int. J. Pharm. 2008, 363, 170-176.
54. Meng, J.; Fan, J.; Galiana, G.; Branca, R. T.; Clasen, P. L.; Ma, S.; Zhou, J.; Leuschner, C.; Kumar, C. S. S. R.; Hormes, J.; Otiti, T.; Beye, A. C.; Harmer, M. P.; Kiely, C. J.; Warren, W.; Haataja, M. P.; Soboyejo, W. O. LHRH-functionalized superparamagnetic iron oxide nanoparticles for breast cancer targeting and contrast enhancement in MRI. Mater. Sci. Eng. C 2009, 29, 1467-1479.
55. Ke, J. H.; Lin, J. J.; Carey, J. R.; Chen, J. S.; Chen, C. Y.; Wang, L. F. A specific tumor-targeting magnetofluorescent nanoprobe for dual-modality molecular imaging. Biomaterials 2010, 31, 1707-1715.
56. Kumagai, M.; Kano, M. R.; Morishita, Y.; Ota, M.; Imai, Y.; Nishiyama, N.; Sekino, M.; Ueno, S.; Miyazono, K.; Kataoka K. Enhanced magnetic resonance imaging of experimental pancrea tumor in vivo by block copolymer-coated magnetite nanoparticles with TGF-β inhibitor. J. Control Release. 2009, 140, 306-311.
57. Vigor, K. L.; Kyrtatos, P. G.; Minogue, S.; Al-Jamal, K. T.; Kogelberg, H.; Tolner, B.; Kostarelos, K.; Begent, R. H.; Pankhurst, Q. A.; Lythgoe, M. F.; Chester, K. A. Nanoparticles functionalised with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells. Biomaterials 2010, 31, 1307-1315.
58. Hogemann, D.; Josephson, L.; Weissleder, R.; Basilion, J. P. Improvement of MRI probes to allow efficient detection of gene expression. Bioconjug. Chem. 2000, 11, 941-946.
59. Goya, G. F.; Berquo, T. S.; Fonseca, F. C. Static and dynamic magnetic properties of spherical magnetite nanoparticles. J. Appl. Phys. 2003, 94, 3520-3528.
60. Chouly, C.; Pouliquen, D.; Lucet, I.; Jeune, J. J.; Jallet, P. Development of superparamagnetic nanoparticles for MRI: effect of particles size, charge and surface nature on biodistribution. J. Microencapsul. 1996, 13, 245-255.
61. Chatterjee, J.; Haik, Y.; Chen, C. J. Size dependent magnetic properties of iron oxide nanoparticles. J. Magn. Magn. Mater. 2003, 257, 113-118.
62. Pratsinis, S. E.; Vemury, S. Particle formation in gases: a review. Powder Technol. 1996, 88, 267-273.
63. Gupta, A. K.; Gupta, M. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials 2005, 26, 1565-1573.
64. Torchilin, V. P.; Trubetskoy, V. S. Which polymers can make nanoparticulate drug carriers long-circulating. Adv. Drug Deliv. Rev. 1995, 16, 141-155.
65. Gao, J.; Xu, B. Applications of nanomaterials inside cells. Nano Today 2009, 4, 37-51.
66. Jain, T. K.; Richey, J.; Strand, M.; Leslie-Pelecky, D. L.; Flask, C. A.; Labhasetwar, V. Magnetic nanoparticles with dual functional properties: Drug delivery and magnetic resonance imaging. Biomaterials 2008, 29, 4012-4021.
67. Zheng, J.; Wang, J.; Tang, T.; Li, G.; Cheng, H.; Zou, S. Experimental study on magnetic drug targeting in treating cholangiocarcinoma based on internal magnetic fields. Chinese-German J. Clin. Oncol. 2006, 5, 336-338.
68. Widder, K. J.; Senyei, A. E.; Ranney, D. F. In vitro release of biologically active adriamycin by magnetically responsive albumin microspheres. Cancer Res. 1980, 40, 3512-3517.
69. Gong, L. S.; Zhang, Y. D.; Liu, S. Target distribution of magnetic albumin nanoparticles containing adriamycin in transplanted rat liver cancer model. Hepatobiliary Pancreat. Dis. Int. 2004, 3, 365-368.
70. Gupta, P. K.; Hung, C. T. Comparative disposition on adriamycin delivered via magnetic albumin microspheres in presence and absence of magnetic field in rats. Life Sci. 1990, 46, 471-479.
71. Gallo, J. M.; Hung, C. T.; Gupta, P. K.; Perrier, D. G. Physiological pharmacokinetic model of adriamycin delivered via magnetic albumin microspheres in the rat. J. Pharmacokinet. Biopharm. 1989, 17, 305-326.
72. Falk, M. H.; Issels, R. D. Hyperthermia in oncology. Int. J. Hyperthermia 2001, 17, 1-18.
73. Horsman, M. R.; Overgaard, J. Hyperthermia: a potent enhancer of radiotherapy. Clin. Oncol. 2007, 19, 418-426.
74. Issels, R. D. Hyperthermia adds to chemotherapy. Eur. J. Cancer. 2008, 44, 2546-2554.
75. Hildebrandt, B.; Wust, P.; Ahlers, O.; Dieing, A.; Sreenivasa, G.; Kerner, T.; Felix, R.; Riess, H. The cellular and molecular basis of hyperthermia. Crit. Rev. Oncol. Hematol. 2002, 43, 33-56.
76. 4 magnetic fluid on tumor ti ssue s in alternating magnetic field. CIESC J. 2009, 60, 833-839.
77. Huber, D. L. Synthesis, properties, and applications of iron nanoparticles. Small. 2005, 1, 482-501.
78. Donadel, K.; Felisberto, M. D. V.; Fávere, V. T.; Rigoni, M.; Batistela, N. J.; Laranjeira, M. C. M. Synthesis and characterization of the iron oxide magnetic particles coated with chitosan biopolymer. Mater. Sci. Eng. C 2008, 28, 509-514.
79. Meenach, S. A.; Hilt, J. Z.; Anderson, K. W. Poly(ethylene glycol)- based magnetic hydrogel nanocomposites for hyperthermia cancer therapy. Acta Biomater. 2010, 6, 1039-1046.
80. Johannsen, M.; Gneveckow, U.; Thiesen, B.; Taymoorian, K.; Cho, C. H.; Waldöfner, N.; Scholz, R.; Jordan, A.; Loening, S. A.; Wust, P. Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution. Eur. Urol. 2007, 52, 1653-1662.
81. Yang, C.; Rait, A.; Pirollo, K. F.; Dagata, J. A.; Farkas, N.; Chang, E. H. Nanoimmunoliposome delivery of superparamagnetic iron oxide markedly enhances targeting and uptake in human cancer cells in vitro and in viro. Nanomedicine 2008, 4, 318-329.
82. Jordan, A.; Scholz, R.; Wust, P.; Schirra, H.; Schiestel, T.; Schmidt, H.; Felix, R. Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro. J. Magn. Magn. Mater. 1999, 194, 185-196.
83. Jordan, A.; Wust, P.; Fahling, H.; John, W.; Hinz, A.; Felix, R. Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. Int. J. Hyperthermia 1993, 9, 51-68.
84. Ito, A.; Shinkai, M.; Honda, H.; Kobayashi, T. Heat-inducible TNF-alpha gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy. Cancer Gene Ther. 2001, 8, 649-654.
85. Brigger, I.; Dubernet, C.; Couvreur, P. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 2002, 13, 631-651.